Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its Stock

MYGN plans to launch its Prolaris + AI Test this month, combining biomarker data and AI pathology to personalize prostate cancer surveillance.

Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...
MedPage Today

Can Gleason Score Reliably Predict Prostate Cancer Outcomes?

The Gleason score reliably predicts lethal prostate cancer for up to 25 years after diagnosis. High-grade prostate cancers progress rapidly in the short term, while lower grade tumors can still lead ...
ascopubs.org

Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?

Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma Gleason grading is an important ...
4029tv

Biden says he has a Gleason score of 9 | Here’s what that means

Shocking health announcement coming from the Biden family. Former President Joe Biden diagnosed with an aggressive form of prostate cancer that has spread to his bones. His personal office releasing ...